JPMorgan Chase & Co’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $4.57M | Buy |
|
|||||
|
2021
Q1 | $593K | Buy |
|
|||||
|
2020
Q4 | $478K | Buy |
|
|||||
|
2020
Q3 | $155K | Sell |
|
|||||
|
2020
Q2 | $203K | Buy |
|
|||||
|
2020
Q1 | $49K | Buy |
|
|||||
|
2019
Q4 | $103K | Hold |
|
|||||
|
2019
Q3 | $83K | Buy |
|
|||||
|
2019
Q2 | $85K | Sell |
|
|||||
|
2019
Q1 | $416K | Buy |
|
|||||
|
2018
Q4 | $158K | Sell |
|
|||||
|
2018
Q3 | $201K | Sell |
|
|||||
|
2018
Q2 | $229K | Buy |
|
|||||
|
2018
Q1 | $44K | Sell |
|
|||||
|
2017
Q4 | $83K | Buy |
|
|||||
|
2017
Q3 | $39K | Sell |
|
|||||
|
2017
Q2 | $119K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $833K | Buy |
|
|||||
|
2016
Q1 | $718K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $1.12M | Sell |
|
|||||
|
2014
Q4 | $1.31M | Sell |
|
|||||
|
2014
Q3 | $2.05M | Buy |
|
|||||
|
2014
Q2 | $2.65M | Buy |
|